Mucosal melanoma is a rare and aggressive subtype of melanoma that has a less favorable
prognosis due to the lack of understanding and identification of oncogenic drivers. Recently …

Melanoma is one of the most highly mutated malignancies, largely as a function of its
generation through ultraviolet light and other mutational processes. The wide array of …

Checkpoint blockade therapies that reactivate tumour-associated T cells can induce durable
tumour control and result in the long-term survival of patients with advanced cancers …

Cutaneous melanoma is a highly immunogenic malignancy that is surgically curable at early
stages but life-threatening when metastatic. Here we integrate high-plex imaging, 3D high …

Outcomes for patients with melanoma have improved over the past decade as a result of the
development and FDA approval of immunotherapies targeting cytotoxic T lymphocyte …

Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral and
maxillofacial region, severely affects human health. However, current treatments for OSCC …

The application and integration of molecular profiling technologies create novel
opportunities for personalized medicine. Here, we introduce the Tumor Profiler Study, an …

Recent developments in oncology have led to a better molecular and cellular understanding
of cancer, and the introduction of novel therapies. Conjunctival melanoma (CoM) is a rare …

Dedifferentiated melanoma (DM) and undifferentiated melanoma (UM) is defined as a
primary or metastatic melanoma showing transition between conventional and …

Melanoma, a lethal malignancy that arises from melanocytes, exhibits a multiplicity of clinico‐
pathologically distinct subtypes in sun‐exposed and non‐sun‐exposed areas. Melanocytes …